Tag: inflammation

The Endocrine Society officially concluded its annual meeting, ENDO 2026, this past June at the McCormick Place convention center in Chicago, Illinois. As one of the premier gatherings for endocrinology professionals globally, the event served as a critical platform for the dissemination of cutting-edge research, the introduction of novel therapeutic modalities, and the facilitation of…

The ENDO 2026 annual meeting concluded this past June in Chicago, marking a pivotal moment for the field of endocrinology during a period of significant transition and economic pressure within the global healthcare sector. Despite a backdrop of fluctuating research budgets and systemic uncertainties, the event drew record-breaking attendance, underscoring the unwavering commitment of the…

The Endocrine Society has officially announced the launch of its new Center on Obesity, a strategic initiative designed to consolidate expert knowledge and address the escalating global health crisis associated with excessive adiposity. This launch coincides with the unveiling of a landmark Scientific Statement titled Obesity Science, Research Gaps and Opportunities in the New Era…

The landscape of endocrine and oncological medicine underwent a significant shift during the final week of August as the U.S. Food and Drug Administration issued two landmark approvals that address some of the most persistent challenges in modern healthcare. On August 26, the regulatory body granted approval for Rasonque (daraxonrasib), a first-in-class targeted therapy for…

The Endocrine Society has officially inaugurated its Center on Obesity, a strategic initiative designed to consolidate research, clinical practice, and advocacy in response to the escalating global obesity epidemic. Accompanying this launch is the release of a seminal Scientific Statement titled "Obesity Science, Research Gaps and Opportunities in the New Era of Obesity Medicines." These…

The annual meeting of the Endocrine Society, known as ENDO, serves as a global stage for the latest breakthroughs in hormone research and clinical practice, but few segments capture the urgency and innovation of the field like the Rising Star Power Talks. At ENDO 2026, held in Chicago, Illinois, Brittany Weisbrot, an internal medicine resident…

The Endocrine Society has officially named Bradley David Anawalt, MD, as the recipient of the 2026 Outstanding Educator Laureate Award, a prestigious recognition that highlights his decades of commitment to the advancement of medical pedagogy and the specialized field of andrology. As a professor and the vice chair of the Department of Medicine at the…

The Endocrine Society, a global organization representing thousands of physicians and scientists specializing in hormone research and clinical care, has officially voiced its support for the introduction of the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act in the U.S. House of Representatives. This bipartisan legislative effort seeks to address the long-standing…

A comprehensive retrospective chart review led by researchers at the University of Michigan has identified a critical deficiency in the adherence to established clinical guidelines for prescribing testosterone therapy. The study, presented at the ENDO 2026 annual meeting, reveals that a vast majority of men initiated on testosterone replacement therapy (TRT) did not receive the…

New clinical data presented at the ENDO 2026 annual meeting has provided robust evidence that menopausal hormone therapy (MHT) plays a critical role in preserving skeletal integrity, significantly lowering the risk of osteopenia and osteoporosis in postmenopausal women. The research, led by Diego Espinoza-Peralta, MD, MSc, Vice President of the Mexican Society of Nutrition and…